Table 1.
Characteristic | Mild, n = 567 (%) |
Moderate-to-severe, n = 538 (%) |
---|---|---|
Sex | ||
Male | 293 (51.7) | 293 (54.5) |
Female | 274 (48.3) | 245 (45.5) |
Age | ||
<6 months | 24 (4.2) | 33 (6.1) |
≥6 to <36 months | 104 (18.3) | 189 (35.1) |
≥3 to <9 years | 212 (37.4) | 177 (32.9) |
≥9 to <18 years | 227 (40.0) | 139 (25.8) |
Race | ||
Asian | 100 (17.6) | 95 (17.7) |
Black | 44 (7.8) | 45 (8.4) |
Hispanic | 184 (32.5) | 185 (34.4) |
Multiracial | 33 (5.8) | 41 (7.6) |
Native American | 2 (0.4) | 1 (0.2) |
Pacific Islander | 4 (0.7) | 2 (0.4) |
Unknown/Other | 7 (1.2) | 4 (0.7) |
White | 193 (34.0) | 165 (30.7) |
Vaccinated in Current Season | ||
Yes | 115 (20.3) | 121 (22.5) |
No | 452 (79.7) | 417 (77.5) |
Influenza Vaccine Primed | ||
Yes | 183 (32.3) | 166 (30.9) |
No | 230 (40.6) | 229 (42.6) |
Unknown | 154 (27.2) | 143 (26.6) |
Comorbidities Presenta | ||
Asthma | 93 (16.4) | 100 (18.6) |
Asthma within 90 Daysb | 21 (3.7) | 40 (7.4) |
Cystic Fibrosis | 0 (0) | 0 (0) |
Congenital Anomalies | 78 (13.8) | 93 (17.3) |
Diabetes Mellitus | 1 (0.2) | 5 (0.9) |
Chronic Otitis Media | 4 (0.7) | 6 (1.1) |
Renal Disorders | 1 (0.2) | 4 (0.7) |
Hepatic Disorders | 8 (1.4) | 8 (1.5) |
Neurological/Neuromuscular Disorders | 10 (1.8) | 18 (3.3) |
Other Metabolic Disorders | 14 (2.5) | 25 (4.6) |
History of Prematurity (<32 weeks) | 19 (3.4) | 39 (7.2) |
Number of Comorbidities | ||
None | 381 (67.2) | 326 (60.6) |
1–2 Comorbidities | 178 (31.4) | 194 (36.1) |
>2 Comorbidities | 8 (1.4) | 18 (3.3) |
Influenza Type & RSV Co-Infection | ||
Influenza A only | 486 (85.7) | 462 (85.9) |
Influenza A with RSV | 1 (0.2) | 14 (2.6) |
Influenza B only | 80 (14.1) | 60 (11.2) |
Influenza B with RSV | 0 (0) | 2 (0.4) |
Specimen Collection | ||
Early (Prior to Jan 12, 2014) | 261 (46.0) | 280 (52.0) |
Late (On or after Jan 12, 2014) | 306 (54.0) | 258 (48.0) |
aIndividual comorbidity categories are not mutually exclusive.
b“Asthma within 90 days” is a subset of the “Asthma” category.
RSV: respiratory syncytial virus.